Scope Fluidics S.A. Logo

Scope Fluidics S.A.

Biotech venture builder creating microfluidic diagnostic systems for healthcare.

SCP | WAR

Overview

Corporate Details

ISIN(s):
PLSCPFL00018
LEI:
259400EUNFX4E2BEHU15
Country:
Poland
Address:
WARSZAWA OGRODOWA 58, 00-876 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Scope Fluidics S.A. is a biotechnology company that develops innovative projects for the medical diagnostics and healthcare sectors using proprietary microfluidic technologies. The company operates on a venture-building model, incubating projects within dedicated special-purpose vehicles (SPVs) with the objective of commercializing and selling the technology to global industry partners. Its flagship project, the BACTEROMIC system, is an advanced diagnostic device designed for rapid and comprehensive assessment of bacterial antibiotic susceptibility to guide targeted therapies. A key milestone validating its business model was the 2022 sale of its Curiosity Diagnostics SPV, developer of the PCR|ONE rapid diagnostic system, to Bio-Rad.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 12:45
Share Issue/Capital Change
Informacje dotyczące subskrypcji prywatnej akcji serii K
Polish 128.1 KB
2025-11-06 12:45
Report Publication Announcement
Podsumowanie subskrypcji prywatnej akcji serii K - Content (PL)
Polish 408 bytes
2025-11-04 12:56
Major Shareholding Notification
Zawiadomienie z art. 69 Ustawy o ofercie
Polish 89.0 KB
2025-11-04 12:56
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 258 bytes
2025-11-02 13:52
Major Shareholding Notification
Zawiadomienie w trybie art. 69 Ustawy o ofercie
Polish 214.8 KB
2025-11-02 13:52
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 316 bytes
2025-11-02 13:39
Major Shareholding Notification
Zawiadomienie w trybie art. 69 Ustawy o ofercie
Polish 216.6 KB
2025-11-02 13:39
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 258 bytes
2025-10-31 17:31
Share Issue/Capital Change
Zawarcie umów objęcia akcji serii K, dookreślenie wysokości kapitału zakładoweg…
Polish 5.4 KB
2025-10-31 12:45
Director's Dealing
Zawiadomienie od Szymona Ruty
Polish 4.3 KB
2025-10-31 12:45
Director's Dealing
Otrzymanie zawiadomienia od Członka Zarządu w trybie art. 19 MAR - Content (PL)
Polish 294 bytes
2025-10-31 10:42
Director's Dealing
Zawiadomienie od Roberta Hołysta
Polish 5.1 KB
2025-10-31 10:42
Director's Dealing
Otrzymanie zawiadomień od Akcjonariusza w trybie art. 19 MAR - Content (PL)
Polish 302 bytes
2025-10-30 13:56
Director's Dealing
Zawiadomienie od TOTAL FIZ
Polish 4.4 KB
2025-10-30 13:56
Major Shareholding Notification
Otrzymanie zawiadomień od Akcjonariusza w trybie art. 19 MAR - Content (PL)
Polish 270 bytes

Automate Your Workflow. Get a real-time feed of all Scope Fluidics S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scope Fluidics S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scope Fluidics S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NOSA Plugs AB Logo
Develops intranasal products for odor control, allergy relief, and smell recovery for B2C/B2B.
Sweden NOSA
Noul Co., Ltd. Logo
AI-powered, automated point-of-care diagnostics for accessible global healthcare.
South Korea 376930
Nuwellis, Inc. Logo
Develops an ultrafiltration system to remove excess fluid from diuretic-resistant patients.
United States of America NUWE
Nyxoah SA Logo
Develops a mask-free, minimally invasive neurostimulation implant to treat Obstructive Sleep Apnea.
United States of America NYXH
OMNICELL, INC. Logo
Automating medication management for healthcare providers with robotics and intelligent software.
United States of America OMCL
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş. Logo
Manufactures automated systems & devices for safe, efficient oncology chemotherapy treatment.
Türkiye ONCSM
Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.
Canada OBI
Onward Medical N.V. Logo
Develops spinal stimulation therapies to restore movement for people with spinal cord injury.
Netherlands ONWD
Orchestra BioMed Holdings, Inc. Logo
Develops bioelectronic & drug/device therapies for hypertension and artery disease.
United States of America OBIO
Organogenesis Holdings Inc. Logo
Develops regenerative biomaterials for wound care, surgical, and sports medicine markets.
United States of America ORGO

Talk to a Data Expert

Have a question? We'll get back to you promptly.